MicroRNA expression profile in undifferentiated gastric cancer

International Journal of Oncology

Volumn 34, Issue 2, 2009, Pages 537-542

  Katada, Takeyasu ^a   Ishiguro, Hideyuki ^a   Kuwabara, Yoshiyuki ^a   Kimura, Masahiro ^a   Mitul, Akira ^a   Mori, Yoichiro ^a   Ogawa, Ryo ^a   Harata, Koshiro ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

microRNA; Profile; Quantitative reverse transcriptase polymerase chain reaction; Undifferentiated gastric cancer

Indexed keywords

MICRORNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; SURVIVAL RATE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; STOMACH NEOPLASMS; YOUNG ADULT;

EID: 64549124430     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000179     Document Type: Article

References (35)

1. Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N and Kitano S: Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Cancer 89: 1418-1424, 2000.
2. Noda S, Soejima K and Inokuchi K: Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma. Jpn J Surg 10: 277-283, 1980.
3. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
4. Liu W, Mao SY and Zhu WY: Impact of tiny miRNAs on cancers. World J Gastroenterol 13: 497-502, 2007.
5. Hutvagner G and Zamore PD: A microRNA in a multiple-turnover RNAi enzyme complex. Science 297: 2056-2060, 2002.
6. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
7. Alvarez-Garcia I and Miska EA: MicroRNA functions in animal development and human disease. Development 132: 4653-4662, 2005.
8. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-2261, 2006.
9. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 435: 828-833, 2005.
10. Cahill S, Smyth P, Finn SP, et al: Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model. Mol Cancer 5: 70, 2006.
11. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005.
12. Jiang J, Lee EJ, Gusev Y and Schmittgen TD: Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33: 5394-5403, 2005.
13. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001.
14. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64: 31-49, 1965.
15. Ming SC: Gastric carcinoma. A pathobiological classification. Cancer 39: 2475-2485, 1977.
16. Sugano H, Nakamura K and Kato Y: Pathological studies of human gastric cancer. Acta Pathol Jpn 32 (Suppl 2): 329-347, 1982.
17. Cheng AM, Byrom MW, Shelton J and Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33: 1290-1297, 2005.
18. Matsubara H, Takeuchi T, Nishikawa E, et al: Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92. Oncogene 26: 6099-6105, 2007.
19. Zhang B, Pan X, Cobb GP and Anderson TA: microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12, 2007.
20. Akao Y, Nakagawa Y and Naoe T: let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29: 903-906, 2006.
21. Kim do N, Chae HS, Oh ST, et al: Expression of viral microRNAs in Epstein-Barr virus-associated gastric carcinoma. J Virol 81: 1033-1036, 2007.
22. Li Z, Zhan W, Wang Z, et al: Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis. Biochem Biophys Res Commun 348: 229-237, 2006.
23. Garzon R, Pichiorri F, Palumbo T, et al: MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci USA 103: 5078-5083, 2006.
24. Fukuda Y, Kurihara N, Imoto I, et al: CD44 is a potential target of amplification within the 11p13 amplicon detected in gastric cancer cell lines. Genes Chromosomes Cancer 29: 315-324, 2000.
25. Fulci V, Chiaretti S, Goldoni M, et al: Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109: 4944-4951, 2007.
26. van Dekken H, Alers JC, Riegman PH, Rosenberg C, Tilanus HW and Vissers K: Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. Am J Pathol 158: 1961-1967, 2001.
27. Kuo HM, Chang LS, Lin YL, et al: Morin inhibits the growth of human leukemia HL-60 cells via cell cycle arrest and induction of apoptosis through mitochondria dependent pathway. Anticancer Res 27: 395-405, 2007.
28. Zuzarte-Luis V, Montero JA, Rodriguez-Leon J, Merino R, Rodriguez-Rey JC and Hurle JM: A new role for BMP5 during limb development acting through the synergic activation of Smad and MAPK pathways. Dev Biol 272: 39-52, 2004.
29. Hsu HC, Wu Y and Mountz JD: Tumor necrosis factor ligand-receptor superfamily and arthritis. Curr Dir Autoimmun 9: 37-54, 2006.
30. Frommer KW, Reichenmiller K, Schutt BS, et al: IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. J Mol Endocrinol 37: 13-23, 2006.
31. Yao J, Duan L, Fan M, Yuan J and Wu X: Notch1 induces cell cycle arrest and apoptosis in human cervical cancer cells: involvement of nuclear factor kappa B inhibition. Int J Gynecol Cancer 17: 502-510, 2007.
32. Robert-Moreno A, Espinosa L, Sanchez MJ, de la Pompa JL and Bigas A: The notch pathway positively regulates programmed cell death during erythroid differentiation. Leukemia 21: 1496-1503, 2007.
33. Baskiewicz-Masiuk M and Machalinski B: The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. Eur J Haematol 72: 420-429, 2004.
34. Smith P, Syed N and Crook T: Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3. Cell Cycle 5: 1262-1264, 2006.
35. Weiss MM, Kuipers EJ, Postma C, et al: Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival. Cell Oncol 26: 307-317, 2004.